Universal Ibogaine Inc (IBO) - Cash Flow Conversion Efficiency

Latest as of April 2025: -0.405x

Based on the latest financial reports, Universal Ibogaine Inc (IBO) has a cash flow conversion efficiency ratio of -0.405x as of April 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-110.36K ≈ $-79.84K USD) by net assets (CA$272.17K ≈ $196.89K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Universal Ibogaine Inc - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how Universal Ibogaine Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read IBO total debt and obligations for a breakdown of total debt and financial obligations.

Universal Ibogaine Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Universal Ibogaine Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Starbox Group Holdings Ltd. Ordinary Shares NASDAQ:STBX	-0.001x
TROUBADOUR RESOURCES INC. F:2QD0	-0.017x
NANOSPHERE F:3NS	-0.003x
Xplore Resources Corp V:XPLR	0.059x
CT UK High Income Ord LSE:CHI	0.025x
Candela Invest SA BR:CAND	0.050x
DCM Financial Services Limited NSE:DCMFINSERV	0.000x
New Star Investment Trust plc LSE:NSI	0.009x

Annual Cash Flow Conversion Efficiency for Universal Ibogaine Inc (2018–2024)

The table below shows the annual cash flow conversion efficiency of Universal Ibogaine Inc from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see Universal Ibogaine Inc stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-07-31	CA$991.11K ≈ $716.95K	CA$-838.61K ≈ $-606.64K	-0.846x	-35.07%
2023-07-31	CA$1.75 Million ≈ $1.27 Million	CA$-1.10 Million ≈ $-793.82K	-0.626x	+43.00%
2022-07-31	CA$3.94 Million ≈ $2.85 Million	CA$-4.33 Million ≈ $-3.13 Million	-1.099x	-100.15%
2021-07-31	CA$-4.46K ≈ $-3.22K	CA$-3.25 Million ≈ $-2.35 Million	729.129x	+3068.20%
2020-07-31	CA$94.89K ≈ $68.64K	CA$-2.33 Million ≈ $-1.69 Million	-24.565x	-433.93%
2019-07-31	CA$197.12K ≈ $142.59K	CA$-906.88K ≈ $-656.02K	-4.601x	-324.00%
2018-07-31	CA$295.22K ≈ $213.56K	CA$-320.34K ≈ $-231.73K	-1.085x	--

About Universal Ibogaine Inc

V:IBO Canada Biotechnology

Market Cap

$1.13 Million

CA$1.56 Million CAD

Market Cap Rank

#30130 Global

#1575 in Canada

Share Price

CA$0.01

Change (1 day)

+0.00%

52-Week Range

CA$0.01 - CA$0.04

All Time High

CA$0.24